Docket
17/151,045,
U.S. Patent Application
(Jan. 15, 2021)
Cite Docket
METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GLP-1 RECEPTOR AGONISTS CONJUGATED TO ANTAGONISTS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR), 17/151,045 (U.S. Pat. App.)
+ More Snippets
Docket
17/366,453,
U.S. Patent Application
Cite Docket
METHODS OF USING A GIP/GLP1 CO-AGONIST FOR THERAPY, 17/366,453 (U.S. Pat. App.)
+ More Snippets
Docket
2:23-cv-08868,
New York Eastern District Court
(Dec. 1, 2023)
Magistrate Judge Lee G. Dunst,
presiding.
Healthcare/Pharmaceutical Personal Injury Product Liability
Cite Docket
Andino v. Novo Nordisk A/S et al, 2:23-cv-08868 (E.D.N.Y.)
+ More Snippets
Docket
17/366,998,
U.S. Patent Application
(July 2, 2021)
Cite Docket
GIP/GLP1 CO-AGONIST COMPOUNDS, 17/366,998 (U.S. Pat. App.)
+ More Snippets
Docket
17/115,773,
U.S. Patent Application
(Dec. 8, 2020)
Cite Docket
GLP-1 COMPOSITIONS AND USES THEREOF, 17/115,773 (U.S. Pat. App.)
+ More Snippets
Docket
62/964,932,
U.S. Patent Application
(Jan. 23, 2020)
Cite Docket
GIP/GLP1 CO-AGONIST COMPOUNDS, 62/964,932 (U.S. Pat. App.)
+ More Snippets
Docket
6:23-cv-00406,
Oklahoma Eastern District Court
(Dec. 4, 2023)
Magistrate Judge D. Edward Snow,
presiding.
Healthcare/Pharmaceutical Personal Injury Product Liability
Cite Docket
King v. Eli Lilly and Company, 6:23-cv-00406 (E.D.Okla.)
+ More Snippets
Docket
3:24-cv-00972,
Tennessee Middle District Court
(Aug. 8, 2024)
District Judge Waverly D. Crenshaw, Jr,
presiding,
Magistrate Judge Jeffery S. Frensley
Healthcare/Pharmaceutical Personal Injury Product Liability
Cite Docket
Pellar v. Novo Nordisk A/S et al, 3:24-cv-00972 (M.D.Tenn.)
+ More Snippets
Docket
2:24-cv-04539,
Pennsylvania Eastern District Court
(Aug. 28, 2024)
DISTRICT JUDGE KAREN S. MARSTON,
presiding.
Healthcare/Pharmaceutical Personal Injury Product Liability
Cite Docket
Pellar v. Novo Nordisk A/S et al, 2:24-cv-04539 (E.D.Pa.)
+ More Snippets
Docket
16/623,756,
U.S. Patent Application
(Dec. 17, 2019)
Cite Docket
METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING ANTAGONISTIC BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR)/GLP-1 RECEPTOR AGONIST FUSION PROTEINS, 16/623,756 (U.S. Pat. App.)
+ More Snippets
Docket
2:24-cv-00840,
Pennsylvania Eastern District Court
(Feb. 26, 2024)
DISTRICT JUDGE KAREN S. MARSTON,
presiding.
Healthcare/Pharmaceutical Personal Injury Product Liability
Cite Docket
King v. Eli Lilly and Company, 2:24-cv-00840 (E.D.Pa.)
+ More Snippets
Docket
16/623,750,
U.S. Patent Application
(Dec. 17, 2019)
Cite Docket
METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) IN COMBINATION WITH GLP-1 AGONISTS, 16/623,750 (U.S. Pat. App.)
+ More Snippets
Docket
62/815,053,
U.S. Patent Application
(March 7, 2019)
Cite Docket
PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST, 62/815,053 (U.S. Pat. App.)
+ More Snippets
Docket
62/818,342,
U.S. Patent Application
(March 14, 2019)
Cite Docket
PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST, 62/818,342 (U.S. Pat. App.)
+ More Snippets
Docket
62/797,963,
U.S. Patent Application
(Jan. 29, 2019)
Cite Docket
PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST, 62/797,963 (U.S. Pat. App.)
+ More Snippets